Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
SCIVANTA MEDICAL CORP (SCVM)
|
Add to portfolio |
|
|
|
| Price: |
$0.05
| | Metrics |
| OS: |
20.9
|
M
| |
|
|
| Market cap: |
$1.05
|
M
| |
|
|
|
Net debt:
|
$196.9
|
k
| |
0.0
|
x Debt/EBITDA
|
|
EV:
|
$1.24
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$177
|
M
| |
0.0
|
x EV/EBITDA
|
|
EBIT
|
$177
|
M
| |
0.0
|
x EV/EBIT
|
| EPS |
$36.31
| |
0.0
|
x P/E
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Oct-31-15 | Oct-31-14 | Oct-31-13 | Oct-31-12 | Oct-31-11 | Oct-31-10 | Oct-31-09 | Oct-31-08 |
| Revenues | 0.0 | 0.1 | 0.1 | 0.3 | 0.9 | 0.1 | 0.0 | 0.0 |
| Revenue growth | -100.0% | 18.5% | -74.6% | -70.3% | 701.5% | | | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.1 | 0.1 | 0.3 | 0.9 | 0.1 | 0.0 | 0.0 |
| Gross margin | | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | | |
| Research and development | | | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | 0.7 |
| General and administrative | 0.2 | 0.4 | 0.3 | 0.2 | 0.7 | 0.9 | 1.3 | 1.5 |
| EBIT | -0.2 | -0.3 | -0.3 | -0.3 | -0.6 | -0.8 | -1.6 | -2.2 |
| EBIT margin | | -428.4% | -378.8% | -95.0% | -65.4% | -713.5% | | |
| Pre-tax income | -0.3 | -0.4 | -0.3 | 0.0 | 0.0 | 0.0 | -1.6 | -2.2 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.2 | -0.5 |
| Tax rate | 0.0% | 0.0% | 0.0% | | | | 11.2% | 23.6% |
| Net income | -0.3 | -0.4 | -0.3 | -0.3 | -0.6 | -0.8 | -1.4 | -1.7 |
| Net margin | | -526.2% | -426.9% | -113.3% | -68.0% | -688.5% | | |
| |
| Diluted EPS | ($0.05) | ($0.07) | ($0.06) | ($0.10) | ($0.02) | ($0.03) | ($0.05) | ($0.06) |
| Shares outstanding (diluted) | 6.4 | 6.1 | 4.7 | 3.1 | 30.2 | 28.2 | 26.9 | 25.8 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|